Sign inGet started

Wolfe Peter

Insider CIK 1954398 · ZVSA Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2025-07-112025-07-1560,100— $060,100SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2023-05-242024-07-18715— $0715SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award2022-12-162022-12-203,000$2.88 $8.6K44,585SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1421,840— $021,840SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1411,763— $011,763SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1418,058— $018,058SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-149,927— $09,927SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1421,840— $021,840SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-1439,708— $039,708SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award deriv2022-12-122022-12-149,927— $09,927SEC↗
ZVSA ZyVersa Therapeutics, Inc. A Award2022-12-122022-12-1441,585— $041,585SEC↗